GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (OTCPK:GLABF) » Definitions » Gross Profit

GLABF (Gemina Laboratories) Gross Profit : $0.00 Mil (TTM As of Oct. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gemina Laboratories Gross Profit?

Gemina Laboratories's gross profit for the three months ended in Oct. 2024 was $0.00 Mil. Gemina Laboratories's gross profit for the trailing twelve months (TTM) ended in Oct. 2024 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Gemina Laboratories's gross profit for the three months ended in Oct. 2024 was $0.00 Mil. Gemina Laboratories's Revenue for the three months ended in Oct. 2024 was $0.00 Mil. Therefore, Gemina Laboratories's Gross Margin % for the quarter that ended in Oct. 2024 was N/A%.

Gemina Laboratories had a gross margin of N/A% for the quarter that ended in Oct. 2024 => No sustainable competitive advantage


Gemina Laboratories Gross Profit Historical Data

The historical data trend for Gemina Laboratories's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Gross Profit Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Gross Profit
- - - -

Gemina Laboratories Quarterly Data
Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Gemina Laboratories's Gross Profit

For the Biotechnology subindustry, Gemina Laboratories's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gemina Laboratories's Gross Profit Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Gross Profit distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Gross Profit falls into.


;
;

Gemina Laboratories Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Gemina Laboratories's Gross Profit for the fiscal year that ended in Jan. 2024 is calculated as

Gross Profit (A: Jan. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gemina Laboratories's Gross Profit for the quarter that ended in Oct. 2024 is calculated as

Gross Profit (Q: Oct. 2024 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Gross Profit for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Gemina Laboratories's Gross Margin % for the quarter that ended in Oct. 2024 is calculated as

Gross Margin % (Q: Oct. 2024 )=Gross Profit (Q: Oct. 2024 ) / Revenue (Q: Oct. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Gemina Laboratories  (OTCPK:GLABF) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Gemina Laboratories had a gross margin of N/A% for the quarter that ended in Oct. 2024 => No sustainable competitive advantage


Gemina Laboratories Gross Profit Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.